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Abstract
Background: Tuberculosis (TB) remains a global public health problem whose effects have major impact in developing
countries like Uganda. This study aimed at investigating genotypic characteristics and drug resistance profiles of
Mycobacterium tuberculosis isolated from suspected TB patients. Furthermore, risk factors and economic burdens that could
affect the current control strategies were studied.
Methods: TB suspected patients were examined in a cross-sectional study at the Mubende regional referral hospital
between February and July 2011. A questionnaire was administered to each patient to obtain information associated with
TB prevalence. Isolates of M. tuberculosis recovered during sampling were examined for drug resistance to first line anti-TB
drugs using the BACTEC-MGIT960TMsystem. All isolates were further characterized using deletion analysis, spoligotyping
and MIRU-VNTR analysis. Data were analyzed using different software; MIRU-VNTR plus, SITVITWEB, BioNumerics and
multivariable regression models.
Results: M. tuberculosis was isolated from 74 out of 344 patients, 48 of these were co-infected with HIV. Results from the
questionnaire showed that previously treated TB, co-infection with HIV, cigarette smoking, and overcrowding were risk
factors associated with TB, while high medical related transport bills were identified as an economic burden. Out of the 67
isolates that gave interpretable results, 23 different spoligopatterns were detected, nine of which were novel patterns. T2
with the sub types Uganda-I and Uganda-II was the most predominant lineage detected. Antibiotic resistance was detected
in 19% and multidrug resistance was detected in 3% of the isolates.
Conclusion: The study detected M. tuberculosis from 21% of examined TB patients, 62% of whom were also HIV positive.
There is a heterogeneous pool of genotypes that circulate in this area, with the T2 lineage being the most predominant.
High medical related transport bills and drug resistance could undermine the usefulness of the current TB strategic
interventions.
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Introduction
Tuberculosis (TB) caused by Mycobacterium tuberculosis remains a
major global public health problem regardless of the modern
diagnostics, chemotherapy and vaccines [1] [2]. The WHO
estimates that more than one third of the world’s population has
been exposed to M. tuberculosis, of which approximately 10% will
develop active TB during their lifetime [3]. In 2011 alone, there
were 8.7 million new TB cases reported, of which 1.4 million
patients succumbed to the disease [3]. Case fatality rates among
HIV infected patients are extremely high, and can be up to 40% in
sub Saharan Africa [4,5]. Uganda is ranked 16th among the 22
countries with the highest TB burden, with an incidence of 299
and a mortality rate of 84 cases per 100,000 per year [6]. TB is
endemic in poor urban and peri-urban areas mainly due to
congested living conditions, high HIV prevalence and malnutri-
tion [7]. Lifestyles have recently become the center of focus with
regards to activation and mortality of TB. Studies carried out in
PLOS ONE | www.plosone.org 1 May 2013 | Volume 8 | Issue 5 | e64745
Taiwan and Nigeria showed that active TB was predominant
among smokers resulting in more case fatalities as compared to
nonsmokers [8,9]. In rural Uganda, TB transmission has been
associated with sharing of cigarettes and straws used in local brew
consumption [10].
The global TB outlook is grim due to the development of multi
drug resistant strains (MDR-TB) which do not respond to the first
line TB therapy (rifampicin and isoniazid) [11,12]. MDR-TB
patients require longer, more expensive and more toxic treatment
regimens, and yet they are less likely to be cured. This represents
an enormous strain on the control of TB in endemic countries with
poor resources, like Uganda [13,14]. According to the latest WHO
reports, MDR-TB prevalence among new and previously treated
patients in Kampala is 1.1% and 11.7%, respectively [12],
remarkably higher than the national MDR-TB prevalence
detected in 1999 [14]. The true picture of MDR-TB in HIV
hotspots like the Mubende district is however yet to be accurately
established. Until then, surveillance of resistance to TB therapeu-
tics and evaluation of the effectiveness of direct observed treatment
short course (DOTS) at a national level remains the cornerstone
for any TB control program in Uganda [15].
Tuberculosis is often referred to as a poverty driven disease
because malnutrition and other diseases predispose latently
infected individuals to TB activation, while poor hygiene practices
and close contact between people enhances transmission [16,17].
The disease also maintains poverty as it affects the most productive
sub population of the society, the young adults [16–18]. It is
reported that even when other national characteristics are taken
into account, countries with a lower TB burden grow faster than
those heavily afflicted [16–18]. Therefore, the link between ill
health and impoverishment has placed health matters high on the
agenda of most developing countries. The problem seems to arise
from the inequitable distribution of quality health care services
which then creates distance and cost barriers for poor commu-
nities [16,18]. Women are the most affected in these areas because
of the triple burden of housework, childcare and employment.
This allows them very little time to access health centers for TB
treatment [18,19]. And, as TB is a chronic condition that requires
regular treatment and special nutrients for nourishing the sick,
costs over time are inevitable.
Molecular epidemiology is a suitable surveillance tool for this
old but fast evolving epidemic as molecular markers are used to
determine whether isolates of the same mycobacterial species
recovered from either the same or different sources are possibly
related [20,21]. This gives the possibility to describe geographical
transmission and trends of strains or clones and to identify risk
factors for infection, which eventually will help to develop
measures of breaking transmission chains [22]. Earlier studies
based on biochemical tests showed that 67% and 32% of patients
in Mulago referral hospital in Kampala, Uganda were infected
with M. africanum subtype II and M. tuberculosis, respectively [23].
However, with the advent of PCR based molecular typing like
spoligotyping, these findings have been refined. The common
feature in the spoligotype pattern for most isolates from Kampala
was the lack of spacer 33–36, 40 and 43. At the time, these profiles
were assigned to M. africanum sub types Uganda-I and Uganda-II
[24,25]. Today, these genotypes are known to be variants of M.
tuberculosis, but still the names Uganda-I and II are commonly used
[25,26]. Recently, MIRU-VNTR has been used to investigate
clonal complexity and distribution of M. tuberculosis genotypes in
clinical TB in central and south western Uganda [27,28].
Combining spoligotyping and MIRU-VNTR is reported to give
a competitive edge over exclusively using one method [21,29].
Mubende is the poorest district in the central region of Uganda
with an HIV prevalence of 18% [15], creating an immune
compromised sub population susceptible to TB infections. To date
there is no study conducted to elucidate the dynamics of
circulating TB genotypes in this area. This study therefore aimed
at investigating genotypic characteristics and drug resistance
profiles of M. tuberculosis isolates from suspected TB patients.
Furthermore, risk factors and economic burdens that could affect
the current control strategies were studied.
Materials and Methods
Ethical Considerations
Full ethical clearance was obtained from the Uganda National
Council for Science and Technology (UNCST). Healthcare
authorities and the research team were briefed about the ethical
issues. Oral consent was obtained from participating patients, next
of kin or caretakers of minors instead of written consent [30]. All
the adjustments were approved as per research ethical mandate
given UNCST. Furthermore, data was anonymously analyzed as
stipulated by the UNCST guidelines of research involving human
as research participants (2.2/b-e/2007).
Study Site
Mubende district is located in the central region of Uganda,
administratively divided into two counties namely; Buwekula and
Kassanda. The counties are further sub-divided into ten sub-
counties; Bagezza, Butologo, Kasambya, Kitenga, Kiyuni, Ma-
dudu, Bukuya, Kassanda, Kiganda and Myanzi. Mubende is
inhabited by approximately 750,000 people, of which 64% live
below the poverty line in population dense urban and peri-urban
sub counties of Bagezza specifically Mubende town council [30]
[15]. Mubende is indeed a convergence of culture and ethnicity
with the majority of inhabitants belonging to the Bantu ethnic
group (Ganda, Basoga, Nyoro, Batooro, Banyankole, Bafumbira),
Nilotics (Acholi) and Hamite (Nyarwanda) ethinic groups [15].
Mubende has one of the lowest TB detection levels in Uganda and
the district’s national TB program is severely hit with treatment
adherence problems [31].
Study Design and Population
This cross sectional study was conducted between February and
July 2011 with the following inclusion criteria; the patient had to
have presented with cervical lymphadenitis and/or a cough that
had persisted for at least two weeks at the Mubende regional
referral hospital. The national tuberculosis program (NTP) is only
run at this referral hospital in the Mubende district and all
persistent ailments are treated here. This implies that the majority
of the residents in this district who met the study’s criteria would
most likely be treated at this facility. The samples collected over
the six months period would therefore give a cross sectional
window into the population dynamics of the district. A total of 344
patients met the above criterion; 41 at the outpatient department
(OPD), 216 at the tuberculosis ward, eight at the pediatric ward
and 79 at the HIV/AIDS department run by the SUSTAIN
program under the Joint clinical research council (JCRC). Part of
the material obtained from this study, focusing on multiple strain
infections, has been published elsewhere [30].
In addition to sample collection, bio data (sex, age, marital
status, weight height etc.) and clinical history such as HIV status
was collected. A questionnaire was administered by an experi-
enced nursing officer to obtain information about the geograph-
ical, socioeconomic and other factors associated with TB
prevalence. The economic analysis was based on income and
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expenditure questions included in Questionnaire S1 [18,19]. To
minimize the level of bias, patients were orientated about the
objectives of this study. Furthermore, the questions were asked or
paraphrased in local languages without changing the gist of the
question. The analysis was done with an intention of giving an
insight into incomes as well as medical related spending behavioral
patterns among TB patients.
Sample Collection, Culturing and Identification of
Mycobacteria
Sputum and/or lymph node aspirates were collected by
qualified and experienced medical personnel. One sample was
collected per patient who had either a cough or lymphadenitis,
and two from those who had both clinical presentations (one from
each anatomical compartment). The samples were analyzed at the
bio-safety level three (BSL3) tuberculosis laboratory at Makerere
University College of Health sciences, and subjected to culture
using standard operating procedures [31,32] [30,32,33]. Cultures
were incubated for up to eight weeks on Lowenstein Jensen (LJ)
slants (BD BBLTM; Franklin lakes, NJ, USA) and six weeks in
Mycobacterium Growth Indicator Tube (MGIT960) (BD BBLTM)
according to the manufactures’ manual. Smears were made from
each sample and stained for fluorescent microscopy. Results were
communicated to the patients’ health facilities for routine
management. Cultures positive for mycobacteria were subjected
to Capilia NeoTM assay (TAUN, Numazu, Japan) to differentiate
between the M. tuberculosis complex (MTC) and non tuberculous
mycobacteria [34]. Results were interpreted as described by
Muwonge et al [30]. Secondary pure cultures were then forward-
ed for DNA harvesting. Results were entered into a computerized
laboratory access database and linked with individual patient
records on the sample reporting form.
Drug Resistance Assay
The MTC cultures were subjected to drug susceptibility testing
using the BACTEC MGIT960TM (BD BBLTM) automated system
for detection of mycobacterial growth and drug susceptibility
according to the manufactures’ manual [33]. Due to logistical
reasons, only the four most used first line TB drugs in Mubende
district were evaluated; isoniazid, rifampicin, ethambutol and
streptomycin [30]. The drug susceptibility test was only run on the
67 isolates which gave results on molecular typing.
Molecular Analysis
Genomic DNA was extracted by heat inactivation of culture
material dissolved in TE buffer and direct use of the supernatant as
template [30]. The standard PCR amplification of the genomic
regions of difference (deletion analysis) was performed as
previously described [34] at the Norwegian Veterinary Institute,
Oslo. A set of primers including RD1, RD4, RD9 and RD12 were
used, differentiating the members of the M. tuberculosis complex.
Spoligotyping were done by GenoscreenH (Lille, France), based
on the protocol using the primers DRa and DRb as described by
[35,36]. Chromosomal DNA of M. tuberculosis strain H37Rv and
M. bovis BCG were used as positive controls and water as a
negative control.
MIRU-VNTR with the standardized panel of 15 loci (424, 577,
580, 802 960 1644 1955, 2163b, 2165, 2401, 2996, 3192, 3690,
4052, 4156) was performed at GenoscreenH [36] using triplex
PCR with fluorescent primers. DNA fragments were separated by
capillary electrophoresis and the size of the PCR products and allel
assignment was determined with GeneMapperH Software (Applied
Biosystems, Paris, France). The results were reported in Roman
numerals representing the number of repeats per locus. The
standard 15 locus MIRU-VNTR was used because it has been
documented to sufficiently define phylogeny and evolution of M.
tuberculosis complex with minimum resource input [37]. Given that
this study was conducted in and for a resource limited country, the
15 locus MIRU-VNTR was regarded as sufficient for analysis.
Data Assembly and Analysis
Information obtained from the questionnaires, HIV status
from case history and corresponding culture results for each
patient were entered and validated in ExcelH 2007. The data
were then imported into Stata (Stata ver. 11/SE for windows,
Stata Corp, College station, TX) for statistical analyses. A
univariable association between M. tuberculosis presence or
absence was computed with cut off set at p#0.25. Variables
that met the above criterion were then included in both the
mixed logistic and linear regression models for risk and
economic factors associated with TB respectively, with sub-
county as the random effect part of the logistic model and tribe
for the linear regression. Standard methods were used to assess
the model fit and validity. Molecular results from GenoscreenH
and the Norwegian Veterinary Institute were entered and
validated in ExcelH 2007. These were then copied into MIRU-
VNTRplus [38], SITVITWEB http://www.pasteur-guadeloupe.
fr:8081/SITVIT_ONLINE/ [39] and BioNumericsH in order to
establish the lineage, sub-types and spoligotype international
types (SIT) designations and generate dendograms. Calculation
of discriminatory power was done as described by Hunter and
Gaston [40].
To analyze the genetic relationship and possible mutation
pathways within the dominant clusters, a minimum spanning
tree (MST) based on a single locus variation (SLV) on MIRU-
VNTR was generated using BioNumericsH version 6.1 (Applied
Maths, Sint-Martens-Latem, Belgium). MST is a tool that takes
a unidirectional graph and extracts the sub-graphs with the
smallest weights [41]. In this study, the MST was created in a
number of steps. First, a cluster analysis was performed on all
strains using the spoligotypes to identify the dominant clusters.
Based on the results from the cluster analysis a unidirectional
network was created based on the MIRU-VNTR results of the
predominant clusters. The nodes (circles) consist of identical
genotypes and the edges (lines) of weights based on number of
mutations (steps) taken from the loci used [41]. Long weights
(steps) indicate multiple mutations, while short weights indicate
few mutations. The MST algorithm was then applied to this
graph to extract all sub-graphs with the minimal overall weight
sum. Hence, the most similar strains are clustered closely
together with short and thick edges, while increasing genomic
variation leads to thin and longer edges. The genetic relatedness
was further expressed as a percentage based on the formula
below.
K(%)~100{ n
1
N
 
|100
K is the genetic relatedness and n is the number of steps between
any two clonal variants. A step means the number of SLV at which
any two clonal variants differ, and is indicated as numbers from 1–
7 on the MST. Therefore each step represents a difference at a
single locus variation. N is the total number of loci used in the
MIRU-VNTR analysis.
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Results
Summary Statistics of Patients
Out of the 344 studied patients, 206 (60%) were male and 138
(40%) were female, with an average age of 31.5 (30.2–33.0) years,
height of 155.7 (153.8–157.4) cm and weight of 50.4 (49.2–51.55)
kg. Forty-seven percent of the patients were married and 41%
single, the rest widowed, divorced or too young to be categorized.
Sputum and cervical lymph node aspirates accounted for 85% and
15% of the total clinical samples collected respectively. The
records on HIV status revealed that 85 (24.7%) were HIV positive,
59 (17%) negative and 203 (59%) had unknown status.
Of the 344 patients, 61 were smear positive on direct fluorescent
microscopy, while M. tuberculosis was isolated from 74 (21.5%)
cases. Of the culture positive patients, 51 (68%) were newly
diagnosed and 23 (32%) were previously treated for TB infections.
Pulmonary TB was the predominant disease, manifested in 88% of
the sampled group. HIV/TB co- infections were detected in 48
(65%) of the culture positive patients. The TB prevalence was
highest and lowest among the Bafumbira (33%) and Basoga (7%)
ethnic groups, respectively (Table 1).
TB Prevalence and Associated Risk Factor
The mixed effects multivariable logistic model shows that an
individual diagnosed with TB (based on culture) was more likely to
be co-infected with HIV. Additionally, TB patients were more
likely to come from a household size of between 6–10 people.
Smoking and a history of previous TB treatment were also
associated with TB prevalence. There was more variation in TB
prevalence between sub-counties than within sub-counties
(Table 2).
Economic Analysis
The economic aspects of tuberculosis were analyzed using a
mixed effects multivariable linear regression model (Table 3).
Fifty-eight percent (n = 199) of the interviewed patients could be
categorized as living below the poverty line as they earned less
than 2500 shillings ( = 1$) per day. Thirty-nine percent did not
report any source of income while only eight percent could earn
enough to spend a dollar per day, the majority of whom fell under
the category of professionals. The model revealed that a female
earned 20,000/ = (8$) per month less than their male counter
parts. On the other hand the older patients ($45 years) earned
25,000/ = (10$) more than the younger patients (#20 years). HIV
positive individuals earned 31,000/ = (12$) more than patients that
were HIV negative. The results also showed that individuals who
on average earned 58,793/ = ($22) and 110,905/ = ($42) spent
most and least on leisure and health respectively. Patients were
more likely to spend most on medicine and medical related
transport bills respectively.
Identification of Isolates
Deletion analysis was performed on 74 isolates of MTC. For an
isolate to be classified as M. tuberculosis, all four genomic regions of
difference examined should be present (RD1, RD4, RD9 and
RD12). A total of 72 isolates were designated as M. tuberculosis. The
remaining two isolates did not yield any bands, the same isolates
did not yield results from MIRU-VNTR and spoligotyping.
Seventy-two isolates were submitted to GenoscreenH for
spoligotyping and MIRU/VNTR. Five out of these isolates gave
multiple amplifications on MIRU-VNTR and weak hybridization
signals on spoligotyping and were excluded from further analysis.
Spoligotyping
Spoligotyping results revealed 23 different spoligo-patterns with
an overall cluster rate of 62% and a discriminatory power of
93.7% (Figure 1). A total of 52 isolates (78%) were grouped in 12
clusters ranging from 2 to 11 isolates (Figure 1 and Table 4).
Fifteen isolates did not cluster, nine of which were novel and thus
did not exist in any of the data bases used for this study. Isolates
Table 1. Prevalence of tuberculosis, geographical and
socioeconomic factors among patients examined at Mubende
regional referral hospital, Uganda.
Variable Label
Number of
patients
TB status
n (%)
Patients Sampled 344 74 (21)
HIV status Negative 60 14 (23)
Positive 82 46 (56)
Unknown 202 14 (7)
Sample type Sputum 294 65 (88)
Lymph node aspirate 50 9 (12)
Sex Male 207 50 (24)
Female 138 24 (17)
Age Youth (,20) 36 7 (19)
Adult (20–45) 257 54 (21)
Old (.45) 52 12 (23)
Marital status Single 143 33 (23)
Married 165 29 (17)
Divorced 26 6 (23)
Widowed 11 5 (45)
Household size ,6 129 10 (7.7)
6–10 200 52 (26)
.10 13 11 (84)
Ethnic group Ganda 69 19 (27)
Nyoro 76 22 (28)
Batooro 23 2 (8)
Bakiga 47 7 (15)
Nyarwanda 27 4 (15)
Basoga 13 1 (7.7)
Banyankole 56 11 (19)
Bafumbira 15 5 (33)
Others* 18 2 (11)
Geographic Sub-county
Buwekula Madudu 40 14 (35)
Kasambya 26 7 (27)
Town council 36 9 (25)
Kiyuni 20 9 (45)
Bagezza 70 17 (24)
Butologo 17 2 (11)
Kassanda Bukuya 27 1 (3)
Myanzi 33 0
Kiganda 19 1 (5)
Kitenga 37 8 (22)
Kasanda 19 1 (5)
doi:10.1371/journal.pone.0064745.t001
Tracking Tuberculosis in Mubende District
PLOS ONE | www.plosone.org 4 May 2013 | Volume 8 | Issue 5 | e64745
that did not exist in the SITVITWEB database were submitted to
the management of the database and were assigned new Shared
international types (Figure 2). SIT420 was the most prevalent with
a cluster rate of 14.8%, and mostly recovered from rural residents
(Figure 1 and Table 4). SIT52, SIT135 and SIT125 also had a
relatively high cluster rate of between 6 and 9%. These too were
predominantly isolated from rural dwellers. Using the MIRU-
VNTR plus online resource the isolates were further differentiated
into six lineages namely T1, T2, CAS, X2 and LAM (Figure 1).
Previous studies have classified M. tuberculosis isolates that belong to
the T2 lineage as Uganda-I and Uganda-II, based on the lack of
hybridization to either spacer 40 or both 40 and 43 respectively
[24,26,27].
MIRU-VNTR
When the isolates were analyzed with MIRU-VNTR plus, the
panel of 15 loci gave an overall discriminatory power of 97.1%.
MIRU-VNTR data are presented in Figure 1. Within cluster
analysis using an unrooted minimum spanning tree (MST) of the
two predominant clusters (Uganda-I and Uganda-II), revealed that
Uganda-II was more homogeneous given the fewer steps and
thicker lines between the clonal variants as well as larger nodes.
This high genetic relatedness is also shown by the narrow range in
the K value (80%–93.3%) (Table 5 and Figure 3). On the other
hand, Uganda-I was quite heterogeneous given the thin, long lines
and more steps between clonal variants as size of circles which
correspond to lower genetic relatedness between the clonal
variants. This is also emphasized by the wide K range (53.3–80%).
Drug Resistance Patterns among the Clinical Isolates
Among the 67 isolates for which the drug susceptibility test was
done, 65% was detected in newly diagnosed and 33% in
previously treated patients (Table 6). Thirteen isolates were
resistance to at least one drug, and the majority of the drug
resistant isolates were recovered from the patients that had been
previously treated for tuberculosis. Isoniazid resistance was found
in SIT4, SIT52 and SIT420, while rifampicin resistance was found
in SIT52 and SIT142. Resistance against streptomycin was found
in SIT26, SIT53, SIT142, SIT1451 and SIT1549, while resistance
to ethambutol was detected in SIT52 and SIT420. Two
individuals from Kassanda harbored isolates that were resistant
to both rifampicin and isoniazid hence classified as MDR-TB
(Table 6). One of them presented as a newly diagnosed TB case
with an unknown HIV status, while the other was HIV positive
with a previously treated TB infection. Both were infected with
SIT52. The isolate from the HIV positive MDR-TB patient was
also resistant to all the other drugs tested in this study.
Table 2. Mixed effects logistic model showing the factors
associated with prevalence of tuberculosis in Mubende
district.
Variables Level
Odd ratio
(95% CI) P-value
HIV status Negative 1 –
Positive 2.7(0.97–7.26) 0.050
Unknown 0.15(0.54–0.46) 0.001
Household size ,6 1 –
6–10 4.8(1.75–13.19) 0.002
.10 0.0039(2) 0.986
TB history Newly diagnosed 1 –
Previously treated 3.3(1.32–8.31) 0.010
Smoking status Non smoker 1 –
Smoker 3.5(1.53–8.35) 0.003
Medical related bills Consultation 1 –
Drugs 5(1.87–16.63) 0.002
Transport 13(4.87–36.53) 0.001
The random effect (sub-county) showed a variance of 1.12 (0.51–2.43).
doi:10.1371/journal.pone.0064745.t002
Table 3. Mixed linear regression model showing the relationship between monthly income in Uganda shillings and social and
health factors among sampled patients with tuberculosis at Mubende regional referral hospital.
Variables Level Coefficient (95% CI) P-value
Sex Male 1 –
Female 220802 (229151–12453) 0.050
Age Young (,20) 1 –
Adults (20–45) 10506 (23186–24200) 0.133
Old (.45) 25524 (8788–42260) 0.003
Household size ,6 1
6–10 7770 (2927–16468) 0.080
HIV status Negative 1 –
Positive 31859 (18793–44926) 0.001
Unknown 891 (210508–12290) 0.878
Items with most expenditure Education 26119 (28635–60873) 0.140
Leisure 58793 (25194–92393) 0.001
Items with least expenditure Education 215898 (239861–8065) 0.193
Health 110905 (65581–156229 0.000
The random effect (tribe) showed a variance of 8296 shillings (3654–18835). At the time of study 1USD was equivalent to 2500 Uganda shillings.
doi:10.1371/journal.pone.0064745.t003
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Figure 1. UPGMA phylogenic tree (MIRU-VNTR plus) based on spoligotype analysis and MIRU-VNTR of Mycobacterium tuberculosis
isolates from patients at the Mubende regional referral hospital, Uganda. Standard International types (SIT), lineages and MIRU-VNTR data
are presented.
doi:10.1371/journal.pone.0064745.g001
Figure 2. Novel spoligopatterns recently assigned SITs in the SITVITWEB database at the WHO supranational laboratory, Institute
Pasteur de Guadeloupe [38].
doi:10.1371/journal.pone.0064745.g002
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Table 4. The estimated transmission rate (cluster rate) of M. tuberculosis genotypes recovered from patients at Mubende regional
referral hospital, Uganda Mubende district.
Lineage SIT Sub-type
Source (%)
Rural Urban
Number of
clusters
Cluster
size (x)
Identical on
both tools** (y)
Cluster rate (%)
RCR ACR
T1 53 25 75 1 4 2 5.4 2.7
T2 52 Uganda-I 86 14 1 7 4 9.5 5.4
T2 125 Uganda-I 100 0 1 5 2 6.7 2.7
T2 135 Uganda-II 58 42 1 7 2 9.5 2.7
T2 420 Uganda-II 64 36 1 11 0 14.8 –
T1–T2 78 0 100 1 3 2 4 2.7
LAM11-ZWE 1549 100 0 1 2 2 2.7 2.7
CAS1-KILI 21 50 50 1 2 2 – 2.7
CAS1-DEHLI 26 0 100 1 4 2 5.4 2.7
LAM3 and S 4 50 50 1 3 3 – 4
Unknown 3500* 0 100 1 2 0 2.7 –
3501* 0 100 1 3 3 4
Total 12
The total number of isolates is 67 (N).
SIT is shared international type, RCR (relative cluster rate) = (x)/N, ACR (Absolute cluster rate) = (y)/N, Urban = (Bagezza and Madudu subcounty), Rural = (the rest of the
sub counties), *Recently assigned SIT, **Spoligotyping and MIRU-VNTR.
doi:10.1371/journal.pone.0064745.t004
Figure 3. An unrooted minimum spanning tree (MST) showing the molecular relationships of clonal variants of Uganda-I and
Uganda-II based on 15 standard MIRU-VNTR loci (Bionumerics 6.1). The purple and green colors represents isolates from urban (Mubende
town council and Bagezza) and rural settings (the rest of the sub counties) respectively. In this figure the length and thickness (edged) and steps
represent the genetic relatedness between any two connected clonal variants. The size of the nodes (circle) represents the number of isolates of the
clonal variants of the T2-Uganda genotypes.
doi:10.1371/journal.pone.0064745.g003
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Discussion
TB Prevalence and Risk Factor Analysis
This study documented the prevalence of tuberculosis among
individuals who presented with a two week’s persistent cough and/
or cervical lymphadenitis at Mubende referral hospital. M.
tuberculosis was isolated from 21% of the patients, 62% of whom
were also HIV positive. This co-infection is also shown by the
mixed effects multivariable logistic regression model which reveals
that a TB infected individual was more likely to either be a case of
TB relapse or HIV/TB co-infection. HIV/TB co-infection has
been documented over the years with various interpretations to the
relationship [4,5]. The incidence and case fatality rates are higher
in HIV infected patients given their immune deficiency [4,5]. A
TB patient was more likely to be a member of a household of
between 6 to 10 individuals. Tuberculosis is an air borne disease,
therefore overcrowding at household level can be a risk [22]. In
South Africa however, findings showed that overcrowding was
more of a risk for children [16]. Studies recently carried out in
Taiwan and Nigeria highlighted the role of cigarette smoking in
the TB pathogenesis and case fatality rates [8,9]. The findings in
this study seem to concur with these studies, because a TB positive
patient was also more likely to be a cigarette smoker.
Economic Analysis
The economic impact of TB is enormous in sub Saharan Africa
[18]. TB positive patients in this study were likely to spend most on
medicine and medically related transport bills. This phenomenon
has also been reported in Zambia where TB patients spend more
on therapy and transport per month [19]. In Mubende, high
transport costs which result from poor transport infrastructure [15]
could have a negative effect on adherence to treatment which
might inherently affect the bacterial susceptibility to current
therapeutics and hence promote drug resistance. TB/HIV is
indeed affecting the breadwinners in this community. Not only is it
affecting the would-be productive age group, but also the
economically sound individuals. This is supported by the
regression model of monthly income of patients which revealed
that HIV infected patients earned more than HIV negative
patients. This could imply that once incapacitated, the families
dependent on these individuals are left helpless, thus the cycle of
poverty described in developing countries [16–19].
The triple burden effect of housework, childcare and employ-
ment allows women in developing countries very little time to
access health centers for TB treatment [16–19]. In Mubende
however, this disadvantageous status could be exacerbated by the
disparity in monthly income, where women earned much less than
their male counterparts. This disparity can be traced back to
pastoral traditions. Women are rarely assigned major economic
responsibilities, which not only limits their ability to earn but also
their health seeking behavior [10].
Molecular Epidemiology
The results demonstrated a genetic heterogeneity of M.
tuberculosis isolates from Mubende. Isolates from the T2 lineage
were the most predominant with a relative cluster rate of 40.5%
which also indicates recent transmission. This finding supports the
suggestion that this lineage is well established in Uganda [25–
28,42], in contrast to other East African countries where the
incidence of T2 is much lower [20]. Previous studies have
Table 5. The percentage genetic relatedness between two
clonal variants.
Number of steps nith Genetic relatedness K (%)
1 93.3
2 86.6
3 80
4 73.3
5 66.6
6 60
7 53.3
Minimum spanning tree calculations are based on the formula in materials and
methods and the steps in Figure 3.
doi:10.1371/journal.pone.0064745.t005
Table 6. Anti-tuberculosis drug resistance in M. tuberculosis isolates from new and previously treated patients at Mubende
regional referral hospital, Uganda.
Resistance pattern Newly diagnosed N (%) Previously treated N (%) Total N (%)
Total tested 45 22 67
Susceptible 36 (80) 18 (82) 54 (81)
Resistance to one drug 9 (13)
R 0 2 2
I 1 2 3
E 1 1 2
S 2 0 2
Resistance to.one drug 4 (6)
I+R* 1 0 1
I+R+E+S* 0 1 1
I+R+E* 1 0 1
I+S 1 0 1
R= rifampicin, I = isoniazid, E = ethambutol, S = Streptomycin, *MDR=multi drug resistance and resistance to Isoniazid and rifampicin.
doi:10.1371/journal.pone.0064745.t006
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classified M. tuberculosis isolates that belong to the T2 lineage as
Uganda-I and Uganda-II [24–26].
SIT125 clustered in a small but peculiar group which to date
had only been isolated in Kampala [25]. In Mubende, it was
however almost exclusively isolated from residents of Madudu and
Butologo. This could be due to the fact that many of the urban
dwellers in Kampala hail from rural areas, and when infected with
chronically debilitating diseases like HIV and TB, it is common
that they return to their ancestral homes in the terminal stages of
disease. This exodus may be the source of SIT125 in these rural
sub-counties of the Mubende district. This geographical exclusivity
seems to fit the epidemiological data which indicates a higher
variation between than within sub-counties. Similarly, SIT26 was
exclusively recovered from urban dwellers, possibly an indication
of differences in urban and rural TB dynamics. This seems to be
supported by the fact that SIT26 is a central Asian TB strain
which are prevalent on the Indian sub-continent [20] and that
hosts from this area mostly settle in urban areas of Africa. SIT53,
SIT1451 and SIT137 are widely prevalent in the former Soviet
Union territories, United States and United Kingdom respectively
[20,21]. Given that these too were predominantly isolated from
urban dwellers, this could reflect the connectivity and mobility
among individuals in urban settings. The study has led to the
identification of four new Shared international types in the
SITVITWEB data base. It is noteworthy that the majority of these
new SITs were recovered from HIV infected patients, supporting
the theory that pathogen evolution is most rampant among HIV
infected patients [43].
Spoligotyping reflects mutations that occur over a long period of
time while MIRU-VNTR with its high definition reflects the subtle
mutations that have occurred over a relatively shorter periods
[21]. Uganda-II was more homogeneous than Uganda-I which
could either imply that there are fewer exogenous clonal variants
of Uganda-II introduced or it has a low mutation propensity. This
difference in polymorphism between the two predominant clusters
could be a reflection of the dynamics occurring at the individual
level [30,43]. The majority of the individuals from which Uganda-
I was isolated were rural residents, something that could support
the hypothesis of a long delay between infection and diagnosis of
TB [10], given the long distance patients in rural areas would have
to travel to access the TB health care services which are usually
found in urban areas of Mubende district [15]. This delay could
then give the infecting M. tuberculosis population enough time to
multiply to levels that can trigger microevolutions [43]. The other
possibility could be exogenous additions of clonal variants of
Uganda-I from Kampala where it is reported to be predominant
[25,42].
Drug Resistance Patterns among the Clinical Isolates
The majority of the isolates recovered were susceptible to the
currently available first line of treatment against tuberculosis.
However, 19% of the isolates were resistant to at least one drug.
There was no difference in the proportions of resistant isolates
recovered from newly diagnosed and previously treated TB cases,
a finding that contradicts previous reports from Uganda [12,14].
This is most likely to be because of the few numbers of drug
resistant isolates recovered which could not statistically support the
detection of differences between and within groups. Two MDR-
TB isolates were recovered, one from a newly diagnosed and one
from a previously treated TB case. The vast majority of resistance
was observed in local genotypes which seems to supports reports
from Turkey suggesting that the bulk of resistant strains are usually
endemic to local populations. This is also most likely to be a
challenge to the current DOTS control strategy in Mubende, since
the most prevalent genotypes also exhibits the highest level of
resistance to drugs used in the first line treatment of TB.
Conclusions
The study detected M. tuberculosis from 21% of examined
patients presenting with TB like symptoms in the Mubende district
of Uganda, 62% of whom were also HIV positive. The majority of
isolates were sensitive to the first line treatment drugs, but
resistance was detected in 19% of the isolates. Molecular analysis
demonstrated a heterogeneous pool of M. tuberculosis strains
circulating in the area. HIV/TB co-infections, high medical
related transport bills and drug resistance could undermine the
usefulness of the current TB strategic interventions.
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